Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Accellta
Haifa, Haifa District, Israelaccellta.com ↗
- Ownership
- Private
- Employees
- ~10
- Development stage
- Commercial
01
Overview
Accellta has developed a proprietary 3D suspension culture platform that enables scalable, GMP-compliant mass production of various high-quality cell types. The company’s innovations support advances in regenerative medicine, alternative ingredients for food tech, and large-scale biomanufacturing. No direct clinical results as the company is not itself developing therapeutics but providing enabling technologies
- Therapeutic areas
- Other
- Modalities
- Stem cell therapyCell therapyInduced pluripotent stem cell derived therapyBiologic (for media and process development)
- Industry
- Contract Manufacturing Organization
02
Partnerships
Not specifically listed; the company invites partnerships with distributors and companies seeking GMP manufacturing/process development support. No major pharma partners named in public sources.
Beyond the preview
Go deeper on Accellta.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Accellta.